Cas:515831-52-4 3-bromo-5-ethoxy-4-methoxybenzonitrile manufacturer & supplier

Chemical Name:3-bromo-5-ethoxy-4-methoxybenzonitrile

CAS.NO:515831-52-4

Synonyms:3-bromo-5-ethoxy-4-methoxybenzenecarbonitrile;3-bromo-5-ethoxy-4-methoxy-benzonitrile;MFCD02256583;3-Bromo-5-ethoxy-4-methoxybenzonitrile

Molecular Formula:C₁₀H₁₀BrNO₂

Molecular Weight:256.09600

HS Code:2926909090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:306.5ºC at 760 mmHg

Density:1.46g/cm3

Index of Refraction:1.56

PSA:42.25000

Exact Mass:254.98900

LogP:2.72808

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN3439

Packing Group:III

Contact us for information like 3-bromo-5-ethoxy-4-methoxybenzenecarbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-5-ethoxy-4-methoxybenzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD02256583 Use and application,3-bromo-5-ethoxy-4-methoxybenzenecarbonitrile technical grade,usp/ep/jp grade.

Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. 3-bromo-5-ethoxy-4-methoxybenzonitrile manufacturer The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. 3-bromo-5-ethoxy-4-methoxybenzonitrile supplier Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. 3-bromo-5-ethoxy-4-methoxybenzonitrile vendor Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. 3-bromo-5-ethoxy-4-methoxybenzonitrile factory Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.